Terug
Ook genoteerd als
FMCQF
OTC
Dagbereik
€ 21,91
€ 22,14
52-Weeksbereik
€ 20,95
€ 30,46
Volume
445.450
50D / 200D Gem.
€ 23,04
/
€ 24,94
Vorige Slotkoers
€ 21,90
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 13,0 | 0,3 |
| P/B | 0,9 | 2,9 |
| ROE % | 6,8 | 3,7 |
| Net Margin % | 5,0 | 3,8 |
| Rev Growth 5Y % | 2,7 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 28,00
+27.1%
Forward K/W
10,7
Forward WPA
€ 2,05
WPA Groei (sch.)
+0,0%
Omzet Sch.
20 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,24
€ 3,12 – € 3,42
|
23 B | 1 |
| FY2029 |
€ 2,94
€ 2,83 – € 3,10
|
22 B | 1 |
| FY2028 |
€ 2,51
€ 2,42 – € 2,66
|
21 B | 2 |
Belangrijkste Punten
Revenue grew 2,74% annually over 5 years — modest growth
Earnings grew 81,81% over the past year
Generating 1,70B in free cash flow
P/E of 12,98 — trading at a low valuation
PEG of 0,14 suggests growth is underpriced
Cash machine — converts 173,41% of earnings into free cash flow
Groei
Revenue Growth (5Y)
2,74%
Revenue (1Y)1,51%
Earnings (1Y)81,81%
FCF Growth (3Y)-6,60%
Kwaliteit
Return on Equity
6,78%
ROIC5,46%
Net Margin4,98%
Op. Margin9,31%
Veiligheid
Debt / Equity
0,76
Current Ratio1,26
Interest Coverage0,00
Waardering
P/E Ratio
12,98
P/B Ratio0,89
EV/EBITDA11,98
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,51% | Revenue Growth (3Y) | 0,45% |
| Earnings Growth (1Y) | 81,81% | Earnings Growth (3Y) | 40,00% |
| Revenue Growth (5Y) | 2,74% | Earnings Growth (5Y) | 0,22% |
| Profitability | |||
| Revenue (TTM) | 19,63B | Net Income (TTM) | 978,00M |
| ROE | 6,78% | ROA | 3,15% |
| Gross Margin | 25,62% | Operating Margin | 9,31% |
| Net Margin | 4,98% | Free Cash Flow (TTM) | 1,70B |
| ROIC | 5,46% | FCF Growth (3Y) | -6,60% |
| Safety | |||
| Debt / Equity | 0,76 | Current Ratio | 1,26 |
| Interest Coverage | 0,00 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 12,98 | P/B Ratio | 0,89 |
| P/S Ratio | 0,65 | PEG Ratio | 0,14 |
| EV/EBITDA | 11,98 | Dividend Yield | 0,03% |
| Market Cap | 12,70B | Enterprise Value | 21,89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 19,63B | 19,34B | 19,45B | 19,40B | 17,62B |
| Net Income | 978,00M | 537,91M | 499,00M | 673,41M | 969,31M |
| EPS (Diluted) | 1,68 | 0,92 | 0,85 | 0,57 | 0,83 |
| Gross Profit | 5,03B | 4,76B | 4,93B | 4,89B | 4,77B |
| Operating Income | 1,83B | 1,39B | 1,37B | 1,51B | 1,85B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 31,00B | 33,57B | 33,93B | 35,75B | 34,37B |
| Total Liabilities | 16,72B | 17,80B | 19,10B | 20,30B | 20,39B |
| Shareholders' Equity | 14,28B | 14,58B | 13,62B | 13,99B | 12,70B |
| Total Debt | 10,80B | 11,00B | 12,08B | 13,21B | 13,32B |
| Cash & Equivalents | 1,60B | 1,18B | 1,40B | 1,27B | 1,48B |
| Current Assets | 7,90B | 7,92B | 8,70B | 8,20B | 7,97B |
| Current Liabilities | 6,25B | 5,66B | 6,11B | 6,47B | 7,26B |